We further identified ERB-B2 receptor tyrosine kinase 3 (ErbB3, also known as HER3) as a key mediator of liver EC-induced chemoresistance and cell growth in CRC cells [16]. The gene discussed is ERBB3; the disease is colorectal carcinoma.